中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2013年
1期
55-57
,共3页
徐海峰%朱旭%陈辉%王晓东%曹广%刘鹏%高嵩%郭建海
徐海峰%硃旭%陳輝%王曉東%曹廣%劉鵬%高嵩%郭建海
서해봉%주욱%진휘%왕효동%조엄%류붕%고숭%곽건해
手术后出血%胰十二指肠切除术%血管造影术
手術後齣血%胰十二指腸切除術%血管造影術
수술후출혈%이십이지장절제술%혈관조영술
Postoperative hemorrhage%Pancreaticoduodenectomy%Angiography
目的 探讨胰十二指肠术后出血的血管造影表现及介入治疗的安全性和疗效.方法 回顾分析2009年8月至2012年6月北京肿瘤医院介入科29例胰十二指肠术后出血行介入治疗患者的临床资料、血管造影表现、介入治疗技术和预后.结果 29例中,6例为消化道出血,21例为腹腔内出血,2例同时有腹腔内及消化道出血,出血时间为术后8 h~72d.血管造影表现为造影剂外渗、假性动脉瘤形成、动脉管壁不光整、局限性狭窄、远端动脉扩张.介入治疗技术成功率93.94%,止血成功率89.66%.3例死亡.结论 介入栓塞治疗是安全有效的技术,应为胰十二指肠术后出血患者的首选治疗.
目的 探討胰十二指腸術後齣血的血管造影錶現及介入治療的安全性和療效.方法 迴顧分析2009年8月至2012年6月北京腫瘤醫院介入科29例胰十二指腸術後齣血行介入治療患者的臨床資料、血管造影錶現、介入治療技術和預後.結果 29例中,6例為消化道齣血,21例為腹腔內齣血,2例同時有腹腔內及消化道齣血,齣血時間為術後8 h~72d.血管造影錶現為造影劑外滲、假性動脈瘤形成、動脈管壁不光整、跼限性狹窄、遠耑動脈擴張.介入治療技術成功率93.94%,止血成功率89.66%.3例死亡.結論 介入栓塞治療是安全有效的技術,應為胰十二指腸術後齣血患者的首選治療.
목적 탐토이십이지장술후출혈적혈관조영표현급개입치료적안전성화료효.방법 회고분석2009년8월지2012년6월북경종류의원개입과29례이십이지장술후출혈행개입치료환자적림상자료、혈관조영표현、개입치료기술화예후.결과 29례중,6례위소화도출혈,21례위복강내출혈,2례동시유복강내급소화도출혈,출혈시간위술후8 h~72d.혈관조영표현위조영제외삼、가성동맥류형성、동맥관벽불광정、국한성협착、원단동맥확장.개입치료기술성공솔93.94%,지혈성공솔89.66%.3례사망.결론 개입전새치료시안전유효적기술,응위이십이지장술후출혈환자적수선치료.
Objective To discuss the angiographic findings and the safety and efficacy of interventional therapy for post-pancreaticoduodenectomy hemorrhage.Methods The clinical data,features of angiography,interventional treatment technology and prognosis of 29 patients underwent postpancreaticoduodenectomy bleeding between August 2009 and June 2012 were retrospectively analyzed in our hospital.Results In all 29 patients,6 cases underwent gastrointestinal bleeding,21 cases of abdominal bleeding,2 cases had abdominal cavity and gastrointestinal bleeding,hemorrhage occured 8 h-72 d after surgery.Angiographic findings including:extravasation of contrast media,and pseudo aneurysm formation,local arterial intima not smooth,stenosis,distal artery branch expansion.The success rate of interventional techniques was 93.94%,hemostatic rate was 90%.3 cases died.Conclusion The embolization therapy is a safe and effective technique,should be as the first-line diagnostic and treatment choice for patients with post-pancreaticoduodenectomy bleeding.